ATE182586T1 - Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung - Google Patents

Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Info

Publication number
ATE182586T1
ATE182586T1 AT94102183T AT94102183T ATE182586T1 AT E182586 T1 ATE182586 T1 AT E182586T1 AT 94102183 T AT94102183 T AT 94102183T AT 94102183 T AT94102183 T AT 94102183T AT E182586 T1 ATE182586 T1 AT E182586T1
Authority
AT
Austria
Prior art keywords
aminophthhaloylhydrazide
composition
application
pharmacological use
pertains
Prior art date
Application number
AT94102183T
Other languages
English (en)
Inventor
Lonid Minin
Slava Saizev
Original Assignee
Medinkor Zmm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinkor Zmm Ag filed Critical Medinkor Zmm Ag
Application granted granted Critical
Publication of ATE182586T1 publication Critical patent/ATE182586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94102183T 1993-02-19 1994-02-12 Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung ATE182586T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530/93A CH683965A5 (it) 1993-02-19 1993-02-19 Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.

Publications (1)

Publication Number Publication Date
ATE182586T1 true ATE182586T1 (de) 1999-08-15

Family

ID=4189123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102183T ATE182586T1 (de) 1993-02-19 1994-02-12 Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Country Status (6)

Country Link
US (1) US5543410A (de)
EP (1) EP0617024B1 (de)
JP (1) JP2693373B2 (de)
AT (1) ATE182586T1 (de)
CH (1) CH683965A5 (de)
DE (1) DE69419640D1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2160104C2 (ru) * 1997-11-06 2000-12-10 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ лечения язвенной болезни и лекарственный препарат для его осуществления
AU4291201A (en) 2000-03-28 2001-10-08 Musa Tazhudinovich Abidov A medicament and method for the production thereof
RU2211036C2 (ru) * 2001-11-20 2003-08-27 Общество с ограниченной ответственностью "Абидофарма" Лекарственный препарат (варианты) и способ его производства
US6953799B1 (en) * 2002-10-30 2005-10-11 Bach Pharma, Inc. Modulation of cell fates and activities by diketo phthalazines
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
RU2302863C2 (ru) * 2003-04-18 2007-07-20 Общество с ограниченной ответственностью "Абидофарма" Лекарственный препарат (варианты)
RU2326870C2 (ru) * 2003-08-04 2008-06-20 Валерий Хажмуратович ЖИЛОВ Применение циклических биоизостеров производных пуриновой системы для лечения расстройств, вызванных нарушениями нитрергической и дофаминергической систем
EP1655301B1 (de) 2003-08-04 2015-03-11 Valery Khazhmuratovich Zhilov Cyclische bioisostere von purinsystemderivaten und darauf basierende pharmazeutische zusammensetzung
RU2406722C2 (ru) * 2004-06-23 2010-12-20 Синта Фармасьютикалс Корп. Соли бис-(тиогидразидамида) для лечения рака
EP2393361B1 (de) * 2009-02-06 2016-12-07 Bach Pharma, Inc. Pharmazeutisch reine phthalazindione, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
WO2010096686A1 (en) * 2009-02-19 2010-08-26 Bach Pharma, Inc. Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
AT509045B1 (de) * 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
CN102971300B (zh) * 2010-03-01 2016-03-02 梅特里奥药品股份公司 5-氨基-2,3-二氢-(2,3-二氮杂萘)-1,4-二酮钠盐的晶型、含有它们的药物制剂以及所述晶型的生产方法
CA2829755A1 (en) 2011-03-23 2012-09-27 Semorex Technologies Ltd. Treatment of proliferative disorders with a chemiluminescent agent
RU2577849C2 (ru) * 2013-09-25 2016-03-20 Общество с ограниченной ответственностью "Сэлвим" Бис(5-амино-1,4-диоксо-1,2,3,4-тетрагидрофталазин-2-ил)цинк, способ его получения, фармацевтическая композиция на его основе, лечебные средства на его основе, способ лечения кожных заболеваний и способ лечения гастрита
US10258620B2 (en) 2014-12-18 2019-04-16 Metriopharm Ag Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form
EP3248602A1 (de) * 2016-05-26 2017-11-29 MetrioPharm AG Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion bei der behandlung von entzündlichen und/oder degenerativen erkrankungen der sehnen, gelenkbänder, gelenkkapseln und schleimbeutel
US20210379063A1 (en) * 2018-10-26 2021-12-09 Immunopharma Plus D.O.O. Oral aminodihydrophthalazinedione compositions and their use in the treatment of non-viral hepatitis
EP3858358A1 (de) * 2020-01-31 2021-08-04 MetrioPharm AG Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion zur behandlung von seltenen chronischen entzündlichen lungenerkrankungen
RU2747467C1 (ru) * 2020-07-17 2021-05-05 Муса Тажудинович Абидов Способ защиты от коронавирусной инфекции

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2453578A (en) * 1944-02-19 1948-11-09 American Cyanamid Co Preparation of chemiluminescent composition of matter
GB1100911A (en) * 1963-08-20 1968-01-24 Benger Lab Ltd Phthalazine derivatives
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
JPS5116430B2 (de) * 1971-08-05 1976-05-24
JPS5023689B2 (de) * 1971-11-29 1975-08-09
US3957776A (en) * 1973-02-28 1976-05-18 Delmar Chemicals Limited Novel phthalazinone compounds
US4011219A (en) * 1975-03-28 1977-03-08 Chugai Seiyaku Kabushiki Kaisha Phthalazine derivatives and salts thereof
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4334069A (en) * 1978-07-24 1982-06-08 Miles Laboratories, Inc. Chemiluminescent phthalhydrazide-labeled hapten conjugates
US4226993A (en) * 1978-07-24 1980-10-07 Miles Laboratories, Inc. Amino-functionalized phthalhydrazides
US4355165A (en) * 1978-07-24 1982-10-19 Miles Laboratories, Inc. Amino-functionalized phthalhydrazide intermediates
US4250180A (en) * 1979-07-16 1981-02-10 Ortho Pharmaceutical Corporation Method of treating arrhythmia
WO1982000641A1 (en) * 1980-08-25 1982-03-04 Ab Kabivitrum Peptide substrates for determination of protease activity
HU181184B (en) * 1980-09-12 1983-06-28 Eszakmagyar Vegyimuevek Composition for replacing kinetine,the effect and membraneactivity of which is similar to citokinine,which composition improves plant productivity,quantity of protein-nitrogen and anion-absorptivity
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
US4665181A (en) * 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
CH683966A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.

Also Published As

Publication number Publication date
JPH07179431A (ja) 1995-07-18
EP0617024A1 (de) 1994-09-28
JP2693373B2 (ja) 1997-12-24
CH683965A5 (it) 1994-06-30
DE69419640D1 (de) 1999-09-02
US5543410A (en) 1996-08-06
EP0617024B1 (de) 1999-07-28

Similar Documents

Publication Publication Date Title
DE69419640D1 (de) Pharmakologische Verwendung von 5-Aminophthaloylhydrazide; ihre Zusammensetzung und Anwendung
FI954718A0 (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
SE9604786D0 (sv) New compounds
FI943421L (fi) 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
FI955336A7 (fi) Varjoaineina käytettäviä trisyklopolyatsamakrosyklofosfonihappoja, nii den komplekseja ja johdannaisia
FI970489L (fi) Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
FI941068A7 (fi) Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
DE69414194D1 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
ATE264309T1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
FI961977L (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
DE69327813D1 (de) Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung
BG98238A (bg) Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
FI955386A7 (fi) 4-p-fluoribentsoyyli-1-piperidinyyli-propoksi-kromen-4-onijohdannaiset , niiden valmistus ja käyttö psykoosin ja skitsofrenian hoidossa
FI971317A7 (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö